Retatrutide

GGG tri-agonist

Overview

A single-molecule triple agonist that activates the GLP-1, GIP and glucagon receptors at once — the most-watched of the next-generation incretin compounds in metabolic research.

Researched effects

Studied for substantial body-weight and fat-mass reduction in trials
Investigated for blood-glucose and insulin-sensitivity regulation
Appetite and food-intake suppression via central incretin signalling
Glucagon arm explored for increased energy expenditure and hepatic-fat reduction

Buy 2 vials, get your 3rd 50% off

Add a strength to your cart

Ask a question on WhatsApp →

View third-party certificates of analysis →Reconstitution calculator →

For research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease. The information above is educational summary of published research, not medical advice or a claim of results.